Skip to main content
. 2020 May 10;21(9):3378. doi: 10.3390/ijms21093378
RCC renal cell carcinoma
BMI body mass index
OS overall survival
CSS cancer-specific survival
OR odds ratio
HR hazard ratio
CI confidence interval
NSS nephron sparing surgery
RN radical nephrectomy
ECOG scale Eastern Cooperative Oncology Group scale
AR androgen receptor
RFS recurrence-free survival
ERβ oestrogen receptor-β
RR relative risk
SNPs single-nucleotide polymorphisms
CSM cancer-specific mortality
VEGF vascular endothelial growth factor
TKI tyrosine kinase inhibitor
mTOR mammalian target of rapamycin
PD-1 programmed cell death protein-1
CTLA-4 cytotoxic T-lymphocyte-associated protein 4
PFS progression-free survival